Skip to main content
SpringerLink
Log in

Medicamenteuze behandeling van chronisch hartfalen

  • Chapter
Handboek hartfalen

  • 2541 Accesses

Abstract

Na het lezen van dit hoofdstuk kunt u de medicamenteuze behandeling van hartfalen beschrijven.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • AIRE, The Acute Infarction Ramipril Efficacy Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821–8.

    Google Scholar 

  • Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. New Engl J Med 1995;332:80–5.

    Article  PubMed  CAS  Google Scholar 

  • CIBIS-II, The Cardiac Insufficiency Bisoprolol Study II: a randomised trial. Lancet 1999;353:9–13.

    Google Scholar 

  • CBO-consensus Hartfalen 2010 (www.cbo.nl/richtlijnen/overzicht-richtlijnen/cardiovasculaire-aandoening).

  • Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. New Engl J Med 1986;314:1547–52.

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. New Engl J Med 1991;325:303–10.

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. New Engl J Med 2001;345:1667–75.

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Ziesche S, Smith R, Anand I, Dunkman WB, Loeb H et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (VHeFT) Study Group. Circulation 1997; 96:856–63.

    PubMed  CAS  Google Scholar 

  • CONSENSUS, The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study. New Engl J Med 1987;316:1429–35.

    Google Scholar 

  • Flather MD, Shibata MC, Coats AJ, Veldhuisen DJ van, Parkhomenko A, Borbola J, Cohen- Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Bohm M, Anker SD, Thompson SG, Poole-Wilson PA; SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005 Feb;26:215–25.

    Google Scholar 

  • Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003;362:772–6.

    Article  PubMed  CAS  Google Scholar 

  • Guyatt GH. The treatment of heart failure. A methodological review of the literature. Drugs 1986;32:538–68.

    Article  PubMed  CAS  Google Scholar 

  • Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000;283:1295–1302.

    Article  PubMed  CAS  Google Scholar 

  • Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. New Engl J Med 1995;333:1670–6.

    Article  PubMed  CAS  Google Scholar 

  • Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A et al. The Euro- Heart Failure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J 2003;24:464–74.

    Article  PubMed  CAS  Google Scholar 

  • Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 2009;374:1840–8.

    Article  PubMed  CAS  Google Scholar 

  • McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767–71.

    Article  PubMed  CAS  Google Scholar 

  • O'Connor CM, Carson PE, Miller AB, Pressler ML, Belkin RN, Neuberg GW et al. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation. Am J Cardiol 1998;82:881–7.

    Article  PubMed  Google Scholar 

  • Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. New Engl J Med 1996;334:1349–55.

    Article  PubMed  CAS  Google Scholar 

  • Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P et al. Effect of carvedilol on survival in severe chronic heart failure. New Engl J Med 2001;344:1651–8.

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. New Engl J Med 1992;327:669–77.

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. New Engl J Med 2003;349:1893–1906.

    Article  PubMed  CAS  Google Scholar 

  • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 2003;348:1309–21.

    Article  PubMed  CAS  Google Scholar 

  • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New Engl J Med 1999;341:709–17.

    Article  PubMed  CAS  Google Scholar 

  • Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003;362:7–13.

    Article  PubMed  CAS  Google Scholar 

  • The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. New Engl J Med 1997;336:525–33.

    Google Scholar 

  • The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991;325:293–302.

    Google Scholar 

  • The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New Engl J Med 1992;327:685–91.

    Google Scholar 

  • Vries RJ de, Veldhuisen DJ van, Dunselman PH. Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines. Am Heart J 2000;139:185–94.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitair Medisch Centrum Groningen, Groningen

    Prof. Dr. A. A. Voors (cardioloog)

Authors
  1. Prof. Dr. A. A. Voors
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Canisius-Wilhelmina Ziekenhuis, Nijmegen

    B. T. J. Meursing (cardioloog) & E. J. P. Lamfers (cardioloog) (cardioloog) &  (cardioloog)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Bohn Stafleu van Loghum, onderdeel van Springer Media

About this chapter

Cite this chapter

Voors, A.A. (2011). Medicamenteuze behandeling van chronisch hartfalen. In: Meursing, B.T.J., Lamfers, E.J.P. (eds) Handboek hartfalen. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-8543-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-8543-0_12

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-8542-3

  • Online ISBN: 978-90-313-8543-0

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation